About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 14599 record(s)
Req # A-2021-000623
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075019-732.Organization: Health Canada
March 2022
Req # A-2021-000653
Adverse Drug Reactions (ADRs) for FUROSEMIDE. Report numbers: E2B_03406733, E2B_03400650, E2B_03484838, E2B_03484971, E2B_03495322, E2B_03495322, 000919565, E2B_03347519, E2B_03478062, E2B_03429750, E2B_03476211, 000921601, E2B_03478098, 000918752,…Organization: Health Canada
March 2022
Req # A-2021-000760
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-101786-296.Organization: Health Canada
March 2022
Req # A-2021-000832
Adverse Drug Reaction (ADR) for PREDNISONE. Report number: E2B_03321797.Organization: Health Canada
March 2022
Req # A-2021-000945
Adverse Drug Reactions (ADRs). Report numbers: E2B_00641916, E2B_00780106, E2B_00791467, E2B_01040198, E2B_03258746, E2B_03408201, E2B_03646652, E2B_03720054, E2B_04098442, E2B_04111061, E2B_04118435, E2B_04123365, E2B_04123514, E2B_04127815,…Organization: Health Canada
March 2022
Req # A-2021-000994
Adverse Drug Reactions (ADRs) for CLOPIDOGREL BISULFATE. Report numbers: E2B_03716623, E2B_03848638.Organization: Health Canada
March 2022
Req # A-2021-001059
Adverse Drug Reaction (ADR) for CLOPIDOGREL BISULFATE. Report number: E2B_03680490.Organization: Health Canada
March 2022
Req # A-2021-001094
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-112226-26.Organization: Health Canada
March 2022
Req # A-2021-001143
Adverse Drug Reactions (ADRs) for ALEMTUZUMAB. Report numbers: E2B_03776172, 945474, 940047, E2B_03710266, E2B_03745274, E2B_03530667, E2B_04039036, E2B_03531220, E2B_03547276, E2B_03553146, 955737, E2B_04074160, E2B_03747912.Organization: Health Canada
March 2022
Req # A-2021-001144
Adverse Drug Reactions (ADRs) for RANITIDINE HYDROCHLORIDE. Report numbers: E2B_03623086, E2B_03745650, 940286.Organization: Health Canada
March 2022